Title |
EGF Enhances Oligodendrogenesis from Glial Progenitor Cells
|
---|---|
Published in |
Frontiers in Molecular Neuroscience, April 2017
|
DOI | 10.3389/fnmol.2017.00106 |
Pubmed ID | |
Authors |
Junlin Yang, Xuejun Cheng, Jiajun Qi, Binghua Xie, Xiaofeng Zhao, Kang Zheng, Zunyi Zhang, Mengsheng Qiu |
Abstract |
Emerging evidence indicates that epidermal growth factor (EGF) signaling plays a positive role in myelin development and repair, but little is known about its biological effects on the early generation and differentiation of oligodendrocyte (OL) lineage cells. In this study, we investigated the role of EGF in early OL development with isolated glial restricted precursor (GRP) cells. It was found that EGF collaborated with Platelet Derived Growth Factor-AA (PDGFaa) to promote the survival and self-renewal of GRP cells, but predisposed GRP cells to develop into O4(-) early-stage oligodendrocyte precursor cells (OPCs) in the absence of or PDGFaa. In OPCs, EGF synergized with PDGFaa to maintain their O4 negative antigenic phenotype. Upon PDGFaa withdrawal, EGF promoted the terminal differentiation of OPCs by reducing apoptosis and increasing the number of mature OLs. Together, these data revealed that EGF is an important mitogen to enhance oligodendroglial development. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 44 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 27% |
Student > Bachelor | 8 | 18% |
Student > Master | 5 | 11% |
Researcher | 5 | 11% |
Student > Doctoral Student | 1 | 2% |
Other | 2 | 5% |
Unknown | 11 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 12 | 27% |
Biochemistry, Genetics and Molecular Biology | 8 | 18% |
Agricultural and Biological Sciences | 4 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Nursing and Health Professions | 1 | 2% |
Other | 4 | 9% |
Unknown | 14 | 32% |